'Saying AI will replace developers is like saying calculator will replace CAs': Techie's post goes viral, others say learn prompt engineeringA data engineer's viral Reddit post challenges the notion that AI will replace developers, comparing it to calculators replacing chartered ...
Meta unveils new AI-driven marketing solutions to help brands accelerate growthMeta has launched AI-powered marketing tools to help brands collaborate with the right creators for better sales growth. New features inclu...
Nykaa yet to reach fair value; financials decently placed: Sandip Sabharwal“In financials, the overall scenario remains constructive but as the deposit rates go up sharply, especially on the term deposit side, we w...
Meta launches Instagram Reels APIs for developersThe APIs will allow developers to schedule Reels and obtain Reels' social engagement stats. Using the new APIs, developers can publish Reel...
Tata Motors probing Nexon EV fire; Pine Labs acquires SetuAfter a video showing a Nexon electric car on fire went viral on social media, Tata Motors said it has launched an investigation into the i...
Costs of raw material for drugs rise by up to 140%API prices of certain drugs like fever and pain relief drug paracetamol and life-saving antibiotic Meropenem (also used for Covid), and ant...
Saurabh Mukherjea says 3 sectors are readying for multi-year bull runMarket veteran Saurabh Mukherjea says the economy would start to grow again by the end of 2020, and the equity market will stand to benefit...
Sun Pharma to acquire 85 per cent stake in Russia's BiosintezBiosintez focuses on the hospital segment with annual revenues of about USD 52 million for 2015.
Orchid Chemicals rallies 7% as promoters plan to hike stake to 45%Shares of Orchid Chemicals gained over 7% following reports that promoters are planning to increase stake in the company by 13% to 45%.
- Global coal prices cool, but weak rupee worries importers
Power cos that use imported coal have got a respite from skyrocketing fuel costs but the depreciation of the rupee has limited their gains.
- Settlement of regulatory issues critical for Ranbaxy
Ranbaxy Laboratories' stock price has reeled under the pressure of regulatory bans imposed by the US drug regulator on its manufacturing fa...
How Budget can help pharma sectorThe Indian pharmaceutical and healthcare industry has witnessed steady growth over past years and is also expected to perform well in the f...
- Now, USV looks for generic gains in a tough US market
In spite of challenging market conditions, more and more Indian pharma companies are entering the US generic drugs market.
- TEVA TO buy local unit for Rs 400 cr
The world’s largest generic drug manufacturer Teva may be close to acquiring domestic company Saraca Labs’ manufacturing plant in Hyderabad...
- Indian drug cos prepare a peptide mix
As blockbuster drugs are set to lose exclusivity in the US, Indian pharma companies are gearing up to tap the fast-growing generic peptide ...
- Reliance Life to enter global generic space
Reliance Life Sciences (RLS) is planning to introduce its first generic drug by 2009 in international markets.
- Windfall for cos eyeing US oncology market
With anti-cancer blockbuster drugs set to go off-patent in the US in the next three to four years, generic players are gearing up to tap th...